Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Leonard

Showing results (411-420 of 422) with videos related to

Pageof 43
Sort By:
Nature Medicine|October 7, 2016
Corrigendum: Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitorsYi Du, Hirohito Yamaguchi, Yongkun Wei, et al.
Nature Medicine|January 19, 2016
Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitorsYi Du, Hirohito Yamaguchi, Yongkun Wei, et al.
Journal of Medicinal Chemistry|October 13, 2021
Discovery of 6-[(3<i>S</i>,4<i>S</i>)-4-Amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-3-(2,3-dichlorophenyl)-2-methyl-3,4-dihydropyrimidin-4-one (IACS-15414), a Potent and Orally Bioavailable SHP2 InhibitorBarbara Czako, Yuting Sun, Timothy McAfoos, et al.
Journal of Medicinal Chemistry|August 14, 2020
Discovery of IACS-9439, a Potent, Exquisitely Selective, and Orally Bioavailable Inhibitor of CSF1RBarbara Czako, Joseph R Marszalek, Jason P Burke, et al.
Nature Metabolism|December 19, 2020
Author Correction: An enolase inhibitor for the targeted treatment of ENO1-deleted cancersYu-Hsi Lin, Nikunj Satani, Naima Hammoudi, et al.
Nature Metabolism|November 24, 2020
An enolase inhibitor for the targeted treatment of ENO1-deleted cancersYu-Hsi Lin, Nikunj Satani, Naima Hammoudi, et al.
BMC Cancer|June 6, 2017
ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)J V Reynolds, S R Preston, B O'Neill, et al.
Journal of Medicinal Chemistry|July 22, 2021
Discovery of IACS-9779 and IACS-70465 as Potent Inhibitors Targeting Indoleamine 2,3-Dioxygenase 1 (IDO1) ApoenzymeMatthew M Hamilton, Faika Mseeh, Timothy J McAfoos, et al.
Science (New York, N.Y.)|March 19, 2016
The atmosphere of Pluto as observed by New HorizonsG Randall Gladstone, S Alan Stern, Kimberly Ennico, et al.
Science (New York, N.Y.)|March 9, 2023
Protein-metabolite interactomics of carbohydrate metabolism reveal regulation of lactate dehydrogenaseKevin G Hicks, Ahmad A Cluntun, Heidi L Schubert, et al.
Pageof 43

Showing results (411-420 of 422) with videos related to

Sort By:
Pageof 43
Nature Medicine|October 7, 2016
Corrigendum: Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitorsYi Du, Hirohito Yamaguchi, Yongkun Wei, et al.
Nature Medicine|January 19, 2016
Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitorsYi Du, Hirohito Yamaguchi, Yongkun Wei, et al.
Journal of Medicinal Chemistry|October 13, 2021
Discovery of 6-[(3<i>S</i>,4<i>S</i>)-4-Amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-3-(2,3-dichlorophenyl)-2-methyl-3,4-dihydropyrimidin-4-one (IACS-15414), a Potent and Orally Bioavailable SHP2 InhibitorBarbara Czako, Yuting Sun, Timothy McAfoos, et al.
Journal of Medicinal Chemistry|August 14, 2020
Discovery of IACS-9439, a Potent, Exquisitely Selective, and Orally Bioavailable Inhibitor of CSF1RBarbara Czako, Joseph R Marszalek, Jason P Burke, et al.
Nature Metabolism|December 19, 2020
Author Correction: An enolase inhibitor for the targeted treatment of ENO1-deleted cancersYu-Hsi Lin, Nikunj Satani, Naima Hammoudi, et al.
Nature Metabolism|November 24, 2020
An enolase inhibitor for the targeted treatment of ENO1-deleted cancersYu-Hsi Lin, Nikunj Satani, Naima Hammoudi, et al.
BMC Cancer|June 6, 2017
ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)J V Reynolds, S R Preston, B O'Neill, et al.
Journal of Medicinal Chemistry|July 22, 2021
Discovery of IACS-9779 and IACS-70465 as Potent Inhibitors Targeting Indoleamine 2,3-Dioxygenase 1 (IDO1) ApoenzymeMatthew M Hamilton, Faika Mseeh, Timothy J McAfoos, et al.
Science (New York, N.Y.)|March 19, 2016
The atmosphere of Pluto as observed by New HorizonsG Randall Gladstone, S Alan Stern, Kimberly Ennico, et al.
Science (New York, N.Y.)|March 9, 2023
Protein-metabolite interactomics of carbohydrate metabolism reveal regulation of lactate dehydrogenaseKevin G Hicks, Ahmad A Cluntun, Heidi L Schubert, et al.
Pageof 43